Cargando…
Author Correction: SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
Autores principales: | Pan, Pan, Shen, Miaomiao, Yu, Zhenyang, Ge, Weiwei, Chen, Keli, Tian, Mingfu, Xiao, Feng, Wang, Zhenwei, Wang, Jun, Jia, Yaling, Wang, Wenbiao, Wan, Pin, Zhang, Jing, Chen, Weijie, Lei, Zhiwei, Chen, Xin, Luo, Zhen, Zhang, Qiwei, Xu, Meng, Li, Geng, Li, Yongkui, Wu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407132/ https://www.ncbi.nlm.nih.gov/pubmed/34465791 http://dx.doi.org/10.1038/s41467-021-25629-w |
Ejemplares similares
-
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
por: Pan, Pan, et al.
Publicado: (2021) -
STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
por: Wang, Wenbiao, et al.
Publicado: (2020) -
AP-1 signaling pathway promotes pro-IL-1β transcription to facilitate NLRP3 inflammasome activation upon influenza A virus infection
por: Wan, Pin, et al.
Publicado: (2022) -
Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome
por: Wang, Wenbiao, et al.
Publicado: (2020) -
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)